SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-21-000055
Filing Date
2021-03-16
Accepted
2021-03-16 16:56:06
Documents
15
Period of Report
2021-03-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20210312.htm   iXBRL 8-K 40444
7 GRAPHIC tcda-20210312_g1.jpg GRAPHIC 5018
  Complete submission text file 0001595585-21-000055.txt   201107

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20210312.xsd EX-101.SCH 2433
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20210312_cal.xml EX-101.CAL 720
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20210312_def.xml EX-101.DEF 1657
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20210312_lab.xml EX-101.LAB 25293
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20210312_pre.xml EX-101.PRE 13200
8 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20210312_htm.xml XML 11265
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 21746652
SIC: 2834 Pharmaceutical Preparations